289 related articles for article (PubMed ID: 29382365)
1. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.
Miyagawa-Hayashino A; Yoshifuji H; Kitagori K; Ito S; Oku T; Hirayama Y; Salah A; Nakajima T; Kiso K; Yamada N; Haga H; Tsuruyama T
Arthritis Res Ther; 2018 Jan; 20(1):13. PubMed ID: 29382365
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
3. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
[TBL] [Abstract][Full Text] [Related]
4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
5. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
[TBL] [Abstract][Full Text] [Related]
7. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
Madda R; Lin SC; Sun WH; Huang SL
J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
[TBL] [Abstract][Full Text] [Related]
8. Similarity and difference between systemic lupus erythematosus and NZB/W F1 mice by multi-omics analysis.
Okuma K; Oku T; Sasaki C; Kitagori K; Mimori T; Aramori I; Hirayama Y; Yoshifuji H
Mod Rheumatol; 2024 Feb; 34(2):359-368. PubMed ID: 36869711
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody repertoire analysis in normal and lupus-prone mice.
Starobinski M; Lacour M; Reininger L; Izui S
J Autoimmun; 1989 Oct; 2(5):657-74. PubMed ID: 2803476
[TBL] [Abstract][Full Text] [Related]
10. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
11. Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A.
Ward JM; Rose K; Montgomery C; Adrianto I; James JA; Merrill JT; Webb CF
Arthritis Rheumatol; 2014 Dec; 66(12):3404-12. PubMed ID: 25185498
[TBL] [Abstract][Full Text] [Related]
12. Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus.
Leung JW; Lau BW; Chan VS; Lau CS; So KF
Restor Neurol Neurosci; 2016 May; 34(3):443-53. PubMed ID: 27163251
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y
BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083
[TBL] [Abstract][Full Text] [Related]
14. Extensively re-organized systemic lymph nodes provide a feasible environment for self-reactivity in lupus-prone NZB × NZW F1 mice.
Kurosawa Y; Ozawa M; Kanda Y; Takeuchi A; Kawamura T; Narita I; Katakai T
Int Immunol; 2017 Dec; 29(12):567-579. PubMed ID: 29202179
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.
Jiang Y; Hirose S; Sanokawa-Akakura R; Abe M; Mi X; Li N; Miura Y; Shirai J; Zhang D; Hamano Y; Shirai T
Int Immunol; 1999 Oct; 11(10):1685-91. PubMed ID: 10508186
[TBL] [Abstract][Full Text] [Related]
16. HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.
Kim YY; Park KT; Jang SY; Lee KH; Byun JY; Suh KH; Lee YM; Kim YH; Hwang KW
Arthritis Res Ther; 2017 Sep; 19(1):211. PubMed ID: 28950886
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in B-1 cells from lupus-prone mice.
Novaes E Brito RR; Xander P; Pérez EC; Maricato JT; Laurindo MF; De Lorenzo BH; Pellegrino R; Bernardo V; Lopes JD; Mariano M
Immunol Invest; 2014; 43(7):675-92. PubMed ID: 24950194
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.
Chang M; Pan MR; Chen DY; Lan JL
Clin Exp Immunol; 2006 Jan; 143(1):167-79. PubMed ID: 16367948
[TBL] [Abstract][Full Text] [Related]
20. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
Kat I; Makdasi E; Fischel R; Eilat D
Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
